Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults

摘要

The present technology relates to a method of reducing seizure frequency in a subject having epilepsy by transdermally administering an effective amount of cannabidiol (CBD) to the subject wherein the seizure frequency is reduced.